3,5-diisopropylsalicylic acid has been researched along with Budd-Chiari Syndrome in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (100.00) | 2.80 |
Authors | Studies |
---|---|
Artru, F; Denys, A; Moschouri, E | 1 |
Han, X; Jiao, D; Li, Y; Mukhiya, G; Pokhrel, G; Pokhrel, S; Zhou, X | 1 |
Geng, X; Guo, X; Shang, Y; Wang, Z; Xu, H; Zhao, Y; Zu, M | 1 |
Ali, M; Kamani, L; Mustafa, K; Shaikh, T; Siddiqui, DK; Tahir, MM | 1 |
2 review(s) available for 3,5-diisopropylsalicylic acid and Budd-Chiari Syndrome
Article | Year |
---|---|
Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome.
Topics: Budd-Chiari Syndrome; Humans; Hypertension, Portal; Liver Cirrhosis; Portasystemic Shunt, Transjugular Intrahepatic; Salicylates; Treatment Outcome | 2022 |
Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis.
Topics: Budd-Chiari Syndrome; Endovascular Procedures; Humans; Portasystemic Shunt, Transjugular Intrahepatic; Retrospective Studies; Salicylates; Treatment Outcome | 2022 |
2 other study(ies) available for 3,5-diisopropylsalicylic acid and Budd-Chiari Syndrome
Article | Year |
---|---|
The change in the liver volume after direct intrahepatic portocaval shunt in patients with Budd-Chiari syndrome with diffuse hepatic vein occlusion.
Topics: Adult; Budd-Chiari Syndrome; Female; Hepatic Veins; Humans; Male; Retrospective Studies; Treatment Outcome | 2023 |
Innovation in direct intrahepatic portosystemic shunt; a developing country experience.
Topics: Budd-Chiari Syndrome; Developing Countries; Hepatic Veins; Humans; Portasystemic Shunt, Transjugular Intrahepatic; Treatment Outcome; Vena Cava, Inferior | 2023 |